vs
Vyome Holdings, Inc(HIND)与REZOLVE AI PLC(RZLV)财务数据对比。点击上方公司名可切换其他公司
Vyome Holdings, Inc的季度营收约是REZOLVE AI PLC的1.0倍($1.2M vs $1.2M),Vyome Holdings, Inc净利率更高(-211.8% vs -1078.8%,领先867.0%)
Vyome Holdings Inc.是一家处于临床阶段的生物制药企业,专注于研发各类皮肤病的创新治疗方案,产品管线覆盖痤疮、特应性皮炎、慢性真菌感染等未被满足的医疗需求,主要业务和市场布局覆盖北美及南亚地区。
REZOLVE AI PLC是总部位于英国的科技企业,开发人工智能驱动的移动互动与即时交易平台,支持用户直接从音频、视频、印刷内容中完成购买,服务欧洲、北美及部分亚太市场的零售、消费品与媒体客户。
HIND vs RZLV — 直观对比
营收规模更大
HIND
是对方的1.0倍
$1.2M
净利率更高
HIND
高出867.0%
-1078.8%
损益表 — Q2 FY2025 vs Q2 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $1.2M | $1.2M |
| 净利润 | $-2.6M | $-13.0M |
| 毛利率 | 48.2% | — |
| 营业利润率 | -222.4% | -808.4% |
| 净利率 | -211.8% | -1078.8% |
| 营收同比 | -36.8% | — |
| 净利润同比 | -64.9% | — |
| 每股收益(稀释后) | $-2.25 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
HIND
RZLV
| Q2 25 | $1.2M | $1.2M | ||
| Q1 25 | $1.1M | — | ||
| Q4 24 | $1.8M | — | ||
| Q3 24 | $2.3M | — | ||
| Q2 24 | $2.0M | — | ||
| Q1 24 | $1.9M | — | ||
| Q4 23 | $2.0M | — | ||
| Q3 23 | $2.2M | — |
净利润
HIND
RZLV
| Q2 25 | $-2.6M | $-13.0M | ||
| Q1 25 | $1.5M | — | ||
| Q4 24 | $2.9M | — | ||
| Q3 24 | $-547.8K | — | ||
| Q2 24 | $-1.6M | — | ||
| Q1 24 | $-2.2M | — | ||
| Q4 23 | $-1.7M | — | ||
| Q3 23 | $-3.5M | — |
毛利率
HIND
RZLV
| Q2 25 | 48.2% | — | ||
| Q1 25 | 61.2% | — | ||
| Q4 24 | -118.6% | — | ||
| Q3 24 | 1.6% | — | ||
| Q2 24 | 57.7% | — | ||
| Q1 24 | 59.9% | — | ||
| Q4 23 | 92.9% | — | ||
| Q3 23 | 59.8% | — |
营业利润率
HIND
RZLV
| Q2 25 | -222.4% | -808.4% | ||
| Q1 25 | -198.2% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -12.3% | — | ||
| Q2 24 | -104.5% | — | ||
| Q1 24 | -113.7% | — | ||
| Q4 23 | -95.7% | — | ||
| Q3 23 | -180.0% | — |
净利率
HIND
RZLV
| Q2 25 | -211.8% | -1078.8% | ||
| Q1 25 | 132.4% | — | ||
| Q4 24 | 160.0% | — | ||
| Q3 24 | -23.9% | — | ||
| Q2 24 | -81.2% | — | ||
| Q1 24 | -112.8% | — | ||
| Q4 23 | -85.7% | — | ||
| Q3 23 | -164.0% | — |
每股收益(稀释后)
HIND
RZLV
| Q2 25 | $-2.25 | — | ||
| Q1 25 | $18.98 | — | ||
| Q4 24 | $-4355.36 | — | ||
| Q3 24 | $-1419.10 | — | ||
| Q2 24 | $-91.56 | — | ||
| Q1 24 | $-135.37 | — | ||
| Q4 23 | $-48.87 | — | ||
| Q3 23 | $-59.36 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | — | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-5.0M | $-14.3M |
| 总资产 | — | $80.1M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
HIND
RZLV
| Q2 25 | — | — | ||
| Q1 25 | $2.5M | — | ||
| Q4 24 | $101.9K | — | ||
| Q3 24 | $743.0K | — | ||
| Q2 24 | $12.0K | — | ||
| Q1 24 | $2.4M | — | ||
| Q4 23 | $4.5M | — | ||
| Q3 23 | $1.4M | — |
股东权益
HIND
RZLV
| Q2 25 | $-5.0M | $-14.3M | ||
| Q1 25 | $1.2M | — | ||
| Q4 24 | $-4.4M | — | ||
| Q3 24 | $1.5M | — | ||
| Q2 24 | $-4.0M | — | ||
| Q1 24 | $4.5M | — | ||
| Q4 23 | $-6.2M | — | ||
| Q3 23 | $3.1M | — |
总资产
HIND
RZLV
| Q2 25 | — | $80.1M | ||
| Q1 25 | $6.5M | — | ||
| Q4 24 | $1.4M | — | ||
| Q3 24 | $1.3M | — | ||
| Q2 24 | $-614.0K | — | ||
| Q1 24 | $8.2M | — | ||
| Q4 23 | $10.7M | — | ||
| Q3 23 | $7.8M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | — | $-4.9M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势,按日历期对齐
经营现金流
HIND
RZLV
| Q2 25 | — | $-4.9M | ||
| Q1 25 | $-2.1M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $1.5M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $-2.1M | — | ||
| Q4 23 | $-2.5M | — | ||
| Q3 23 | $-2.8M | — |
资本支出强度
HIND
RZLV
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | 0.0% | — | ||
| Q3 23 | 0.0% | — |
现金转化率
HIND
RZLV
| Q2 25 | — | — | ||
| Q1 25 | -1.44× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图